Prevalence and Isotypic Complexity of the Anti-Chinese Hamster Ovary Host Cell Protein Antibodies in Normal Human Serum
Authors:
- 15 December 2009
- journal article
- Published by Springer Nature in The AAPS Journal
- Vol. 12 (1) , 98-106
Abstract
Host cell-derived protein impurities may be present at low levels in biopharmaceutical products. Antibodies to host cell proteins are present in individuals with no known exposure to these products. In this study, antibodies to drug process-specific Chinese hamster ovary host cell-derived proteins (CHO-HCP) were measured in unexposed individuals using a validated enzyme-linked immunosorbent assay. Samples that tested positive for anti-CHO-HCP reactivity were further characterized to determine the isotypes and IgG subclasses expressed in each positive individual. The specificity of the detected anti-CHO-HCP antibody isotypes was confirmed by the competitive inhibition assay and the uncoated plate specificity testing. These antibody characterization experiments revealed that the prevalent anti-CHO-HCP antibody subclasses were predominantly IgG1 (present in 66.6% of individuals) and IgG2 (60%), with 33.3% positive for IgG3 while IgG4 was detected in low abundance. Forty percent (40%) of the individuals with IgG type reactivity were also identified as IgM-positive. Anti-CHO-HCP-specific IgE was not detected in the assays used in this study. Some individuals exhibited single isotype anti-CHO-HCP reactivity; others contained a combination of multiple antibody isotypes. Data presented in this study demonstrate the isotypic complexity and the high prevalence of anti-CHO-HCP antibodies in human serum with no known exposure to CHO cell-derived therapeutic biologics.Keywords
This publication has 27 references indexed in Scilit:
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsJournal of Pharmaceutical and Biomedical Analysis, 2008
- Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsJournal of Immunological Methods, 2008
- Production systems for recombinant antibodiesFrontiers in Bioscience-Landmark, 2008
- A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugsNature Biotechnology, 2007
- Inhaled cytokines and cytokine antagonistsAdvanced Drug Delivery Reviews, 2006
- Production of recombinant protein therapeutics in cultivated mammalian cellsNature Biotechnology, 2004
- High‐Level Expression of Recombinant IgG in the Human Cell Line PER.C6Biotechnology Progress, 2003
- PLACENTAL TRANSFER OF MATERNAL ANTI‐RABBIT IgG CAUSING FALSELY ELEVATED TSH LEVELS IN NEONATESActa Paediatrica, 1981
- Population Study of Heterophile AntibodiesVox Sanguinis, 1980
- Correlation between Serum IgG-2 Concentrations and the Antibody Response to Bacterial Polysaccharide AntigensNew England Journal of Medicine, 1980